The FDA is saying they have manufacturing issues in a CRL (Complete Response Letter). Nothing about the drug itself. Makes me want to but more but could be more than a year before we see $15+ again.Why is it dropping?
The FDA didn't give specifics in the letter and CRMD is looking to schedule a meeting do they can get started on correcting the issues.